Free article by Nobel laureate available

Nov 14, 2006

The U.S. journal Molecular and Cellular Proteomics has made an article published by Nobel Laureate Andrew Fire available free to the public.

In the journal paper, Fire and colleagues report on their development of an assay that allows them to observe the interactions between proteins in vivo.

The article, which appears in the November issue of the journal, is entitled "A Differential Cytolocalization Assay for Analysis of Macromolecular Assemblies in the Eukaryotic Cytoplasm."

Fire was awarded the 2006 Nobel Prize in Physiology or Medicine along with. Craig Mello for their discovery of RNA interference (RNAi).

The researchers tested the assay in C. elegans, using it to probe interactions among proteins involved in RNA interference (and nonsense mediated decay, or NMD pathways. Several previously documented interactions were confirmed with the assay and many new ones were observed.

Fire and colleagues also used the assay to test a subset of the RNAi and NMD interactions in animals mutant for proteins central to each mechanism and were able to identify several key associations that occurred in the improperly functioning processes.

The article can be found at Bethesda, Md., organization's Web site: mcponline.org.

Copyright 2006 by United Press International

Explore further: What's happening with your donated specimen?

add to favorites email to friend print save as pdf

Related Stories

Davos elites warned about catastrophic cyberattacks

10 hours ago

Attacks on power plants, telecommunications and financial systems, even turning all of Los Angeles' traffic lights green: Davos elites were warned Saturday of the terrifying possibilities of modern cyber ...

Recommended for you

What's happening with your donated specimen?

5 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.